⌘K

Login Start Free

Home/Filings/4/0001209191-23-002029

4//SEC Filing

Yazji Salim 4

Accession 0001209191-23-002029

CIK 0001260990other

View on SEC.gov Company Profile

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 6:00 PM ET

Size

4.8 KB

Accession

0001209191-23-002029

Insider Transaction Report

Form 4

Period: 2023-01-03

Oncternal Therapeutics, Inc.ONCT

Chief Medical Officer

Transactions

Tax Payment
Common Stock
2023-01-03$1.02/sh−9,961$10,160→ 139,676 total

Footnotes (1)

[F1]Shares withheld by the Issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Oncternal Therapeutics, Inc.

CIK 0001260990

Entity typeother

Related Parties

1

filerCIK 0001864486

Filing Metadata

Form type: 4
Filed: Jan 4, 7:00 PM ET
Accepted: Jan 5, 6:00 PM ET
Size: 4.8 KB

View on SEC.gov